Biomarker responses to folic acid intervention in healthy adults: a meta-analysis of randomized controlled trials.

Association of cardiometabolic risk profile with prehypertension accompany hyperhomocysteinaemia.
4 agosto 2017
Circulating unmetabolized folic Acid: relationship to folate status and effect of supplementation.
4 agosto 2017

Biomarker responses to folic acid intervention in healthy adults: a meta-analysis of randomized controlled trials.

Am J Clin Nutr. 2014 Jan;99(1):96-106. doi: 10.3945/ajcn.113.062752. Epub 2013 Nov 13.

Duffy ME, Hoey L, Hughes CF, Strain JJ, Rankin A, Souverein OW, Dullemeijer C, Collings R, Hooper L, McNulty H.

Abstract

BACKGROUND:

The task of revising dietary folate recommendations for optimal health is complicated by a lack of data quantifying the biomarker response that reliably reflects a given folate intake.

OBJECTIVE:

We conducted a dose-response meta-analysis in healthy adults to quantify the typical response of recognized folate biomarkers to a change in folic acid intake.

DESIGN:

Electronic and bibliographic searches identified 19 randomized controlled trials that supplemented with folic acid and measured folate biomarkers before and after the intervention in apparently healthy adults aged ≥18 y. For each biomarker response, the regression coefficient (β) for individual studies and the overall pooled β were calculated by using random-effects meta-analysis.

RESULTS:

Folate biomarkers (serum/plasma and red blood cell folate) increased in response to folicover the counter antibiotics acid in a dose-response manner only up to an intake of 400 μg/d. Calculation of the overall pooled β for studies in the range of 50 to 400 μg/d indicated that a doubling of folic acid intake resulted in an increase in serum/plasma folate by 63% (71% for microbiological assay; 61% for nonmicrobiological assay) and red blood cell folate by 31% (irrespective modalert of whether microbiological or other assay was used). Studies that used the microbiological assay indicated lower heterogeneity compared with studies using nonmicrobiological assays for determining serum/plasma (I(2) = 13.5% compared with I(2) = 77.2%) and red blood cell (I(2) = 45.9% compared with I(2) = 70.2%) folate.

CONCLUSIONS:

Studies administering >400 μg folic acid/d show no dose-response relation and thus will not yield meaningful results for consideration when generating www.yourcanadianmeds.com/product/phentermine/ dietary folate recommendations. The calculated folate biomarker response to a given folic acid intake may be more robust with the use of a microbiological assay rather than alternative methods for blood folate measurement.